During the second meeting of the World Health Organization's (WHO) Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG), November 5-10, 2007 in Geneva, Switzerland. Seminar speakers included (with presentations): Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences Network (WABNet), Senegal - Presentation (PDF 5.89 MB) Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), US Department of Health & Human Services, USA - Presentation (PDF 404 KB) Ted Roumel, Vice President for Research Innovation & Commercialization at the University of Maryland Biotechnology Institute, USA - Presentation (PDF 130 KB) Janna Tom, Assistant Director, Office of Technology Transfer, University of California; Vice President for Public Policy, Association of University Technology Managers (AUTM), USA - Presentation (PDF 216 KB) Eileen Yen, former Director, Sarawak Biodiversity Centre, Malaysia - Presentation (PDF 1.42 MB)</p>
The Biotechnology Industry Organization
Presents a Luncheon Seminar:
From Biotechnology Innovation to Global Health Solutions: Solutions for Diseases Affecting Developing Countries
Wednesday, 07 November 2007
13h00 to 15h00
Pavilion of the Ecole Hôtelière de Genève
situated behind the Vieux Bois Restaurant, at 12 Avenue de la Paix
Biotechnology innovation holds the promise of addressing many of the world’s most pressing challenges. Through biotechnological processes, biotechnology enterprises are developing innovative solutions in healthcare, industrial and environmental applications, and food and agriculture. These enterprises, which are in general small- and medium-sized companies, have spent tens of billions of dollars on the development of cutting edge products which are currently in various stages of development. Dozens of small- and medium-sized biotechnology companies are already engaged in the development of solutions applicable to diseases which disproportionately affect developing countries, and many more are on the verge of engagement.
A panel of experts will not only discuss the critical role of biotechnology in the development of these solutions, but also how companies can be incentivized to move into this area. The panel will discuss the composition of the biotechnology “ecosystem” and describe each player’s role in the process as well as the challenges they face. The group will also provide examples of successful public private partnerships and the workings of incentives useful in driving the development of global health solutions.
13:00 – 13h20
Welcome; guests are invited to partake of a light buffet before the program begins
The role of universities in biotechnology product development and capacity building
Association of University Technology Managers:
Jana Tom, University of California Systems, and
Ted Roumel, University of Maryland Biotechnology Institute
14h00 - 14h45
Government’s role in developing solutions for diseases that disproportionately affect
Mark Rohrbaugh, US National Institutes of Health Director of Office of Technology Transfer.
Eileen Yen, former director of the Sarawak Biodiversity Center in Malaysia
Professor Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences
14:45 – 15:00
Summary and closing
RSVP: Ms. Patricia Natali, Sidley Austin LLP: email@example.com (022 308 0005)